Brief: Arterra Bioscience Files Patent For Natural Compound Interfering With COVID-19
04/08/2020 17:35
Aug 4 (Reuters) - Arterra Bioscience SpA ABIS.MI :
* FILES PATENT FOR NATURAL COMPOUND CAPABLE OF INTERFERING
WITH
COVID-19 INFECTION
Source text for Eikon: ID:nBIA9fCwyq
Further company coverage: ABIS.MI
(Gdansk newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 5110;))
Recent news on Arterra Bioscience SpA
See all newsBrief: Arterra Bioscience - Q1 Revenue EUR 1.6 Million
Brief: Arterra Bioscience Re-Food Project Approved For Financing, Granted Non-Repayable Contribution Of Around EUR 0.5 Mln
Brief: Arterra Bioscience FY Net Profit EUR 2.0 Mln
Brief: Arterra Bioscience FY Revenue At EUR 4.6 Mln
Brief: Arterra Bioscience Shareholder Maria Gabriella Colucci Sells 466,500 Shares At EUR 3.20/SHR To Smart Capital